Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 2/20 | 0.50 |
| ▸ | CDK1 | P06493 | 2/20 | 0.50 |
| ▸ | CDK4 | P11802 | 2/20 | 0.50 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.50 |
| ▸ | CCND1 | P24385 | 2/20 | 0.50 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.50 |
| ▸ | CDK2 | P24941 | 2/20 | 0.50 |
| ▸ | CDK9 | P50750 | 2/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | CDK7 | P50613 | 1/20 | 0.50 |
| ▸ | CCNH | P51946 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL139295 | 1.00 | CCNT1 (0.50) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL3291148 | 0.88 | ALDH1A1 (0.67) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL3291145 | 0.88 | ALDH1A1 (0.67) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL28552816 | 0.84 | GLB1 (0.56) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL146200 | 0.84 | CCNT1 (0.41) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL14366689 | 0.84 | MAPT (0.70) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL146201 | 0.84 | CCNT1 (0.41) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL4349980 | 0.84 | NPC1 (0.58) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL4349981 | 0.84 | NPC1 (0.58) | CCNT1CDK1CDK4CCNB1CCND1 | |
| SCHEMBL17527053 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636634-B2 | Fluorinated MOF materials having rectangular channels, method of synthesizing MOF materials and methods of using MOF materials including for CO2 capture | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2026-05-26 | — | — | US | claimed |
| US-20240316530-A1 | FLUORINATED MOF MATERIALS HAVING RECTANGULAR CHANNELS, METHOD OF SYNTHESIZING MOF MATERIALS AND METHODS OF USING MOF MATERIALS INCLUDING FOR CO2 CAPTURE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2024-09-26 | — | — | US | claimed |
| WO-2024196666-A1 | FLUORINATED MOF MATERIALS HAVING RECTANGULAR CHANNELS, METHOD OF SYNTHESIZING MOF MATERIALS AND METHODS OF USING MOF MATERIALS INCLUDING FOR CO2 CAPTURE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2024-09-26 | — | — | WO | claimed |
| CN-109422771-B | Hydrothermally stable anion pillared hybrid porous material and preparation method and application thereof | 浙江大学 | 2020-07-24 | — | — | CN | claimed |
| CN-109420480-B | Method for separating carbon tetraolefin mixture | 浙江大学 | 2020-06-09 | — | — | CN | claimed |
| CN-108558917-B | Zinc-furandicarboxylic acid organic framework material and preparation method thereof | 江西省科学院应用化学研究所 | 2020-03-31 | — | — | CN | claimed |
| US-9856190-B2 | 1, 3-butadiene separating material, and separation method using said separating material | SHOWA DENKO K.K. (JP) | 2018-01-02 | — | — | US | claimed |
| US-20160159712-A1 | 1, 3-BUTADIENE SEPARATING MATERIAL, AND SEPARATION METHOD USING SAID SEPARATING MATERIAL | SHOWA DENKO K.K. (JP) | 2016-06-09 | — | — | US | claimed |
| US-4180569-A | 4,4*-AZODIPYRIDINE AND ITS SALTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-12-25 | — | — | US | claimed |
| US-12636634-B2 | Fluorinated MOF materials having rectangular channels, method of synthesizing MOF materials and methods of using MOF materials including for CO2 capture | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2026-05-26 | — | — | US | disclosed |
| US-12629639-B2 | Spacer for a spiral wound membrane | EVOVE LTD (GB) | 2026-05-19 | — | — | US | disclosed |
| US-20240316530-A1 | FLUORINATED MOF MATERIALS HAVING RECTANGULAR CHANNELS, METHOD OF SYNTHESIZING MOF MATERIALS AND METHODS OF USING MOF MATERIALS INCLUDING FOR CO2 CAPTURE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2024-09-26 | — | — | US | disclosed |
| WO-2024196666-A1 | FLUORINATED MOF MATERIALS HAVING RECTANGULAR CHANNELS, METHOD OF SYNTHESIZING MOF MATERIALS AND METHODS OF USING MOF MATERIALS INCLUDING FOR CO2 CAPTURE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2024-09-26 | — | — | WO | disclosed |
| EP-4397399-A2 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2024-07-10 | — | — | EP | disclosed |
| US-9239327-B2 | Particles comprising hollow surface-enhanced spectroscopy (SES)-active core for long wavelength SERS | SICPA HOLDING SA (CH) | 2016-01-19 | — | — | US | disclosed |
| US-20120057165-A1 | Particles and Methods for Long Wavelength SERS | CABOT SECURITY MATERIALS INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-20120057165-A1 | Particles and Methods for Long Wavelength SERS | CABOT SECURITY MATERIALS INC. (US) | 2012-03-08 | — | — | US | disclosed |
| WO-2010133849-A1 | DETECTION OF TARGET ANALYTE BY SIGNAL AMPLIFICATION | RENISHAW DIAGNOSTICS LIMITED (GB) | 2010-11-25 | — | — | WO | disclosed |
| US-4180569-A | 4,4*-AZODIPYRIDINE AND ITS SALTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
| US-4180569-A | 4,4*-AZODIPYRIDINE AND ITS SALTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159712-A1 | 1, 3-BUTADIENE SEPARATING MATERIAL, AND SEPARATION METHOD USING SAID SEPARATING MATERIAL | MSL1, LANCL2, ACSL1 | CCNT1 237/4885CDK1 412/4885CDK4 1337/4885 |
| US-12636634-B2 | Fluorinated MOF materials having rectangular channels, method of synthesizing MOF materials and methods of using MOF materials including for CO2 capture | MLX, BMP4, F13B | CCNT1 2962/4885CDK1 2255/4885CDK4 2077/4885 |
| US-12629639-B2 | Spacer for a spiral wound membrane | AQP1, AQP3, AQP4 | CCNT1 782/4885CDK1 2107/4885CDK4 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.